Cardiovascular Indices of Peripheral and Central Sympathetic Activation
Кардиоваскулярные показатели периферической и центральной симпатической активации
2001-09-01
SCID: 54.1/phcfzvt5
Discuss with AI
arterial baroreceptorsimpedance cardiographylow-frequency blood pressure variabilitypreejection periodsympathetic nervous system
Figures from the paper
Abstract (AI)
OBJECTIVE: A number of sympathetic nervous system (SNS) parameters have been used in cardiovascular psychophysiology. This study aimed to describe the pattern and redundancy of a set of SNS parameters during peripherally induced changes of cardiac sympathetic activation and reflex modulation of central SNS control. Preejection period (PEP) was assessed as a marker of peripheral sympathetic activation. Low-frequency blood pressure variability (BPV) was assessed as an estimate of central SNS control. METHODS: Peripheral beta-sympathetic stimulation and blockade were achieved with epinephrine and esmolol hydrochloride (beta1-blockade), respectively. Changes in central SNS output were induced by loading and unloading arterial baroreceptors with norepinephrine and nitroprusside sodium, respectively. This single-blinded, crossover study in 24 healthy men also included two placebo control periods. PEP was derived from impedance cardiography and adjusted individually for heart rate. BPV was calculated by power spectral analyses of beat-to-beat heart rate and systolic blood pressure (Finapres system) data. RESULTS: PEP decreased during epinephrine infusion (-40.1 +/- 3.8 ms, p <.0001) and increased during esmolol infusion (+6.6 +/- 3.5 ms, p =.05). PEP was shortened after central SNS activation by nitroprusside (-16.8 +/- 2.9 ms, p < 0.0001). Systolic BPV in the low-frequency range (0.07-0.14 Hz, Mayer waves) increased during nitroprusside infusion (+0.44 +/- 0.19 ln mm Hg(2), p =.03) and decreased during norepinephrine infusion (-0.67 +/- 0.13 ln mm Hg(2), p < 0.0001). Low-frequency BPV did not change significantly during epinephrine or esmolol infusion. CONCLUSIONS: Our data provide empirical evidence of separable peripheral and central sympathetic response components. The combined report of low-frequency BPV and PEP gives distinct information on both central SNS control and the level of sympathetic cardiac activation achieved.
Key Findings
1
Central sympathetic activation induced by nitroprusside shortened PEP by 16.8 ± 2.9 ms and increased low-frequency systolic BP variability by 0.44 ± 0.19 ln mm Hg².
2
Epinephrine markedly shortened heart-rate-adjusted PEP by 40.1 ± 3.8 ms, whereas esmolol increased PEP by 6.6 ± 3.5 ms.
3
Low-frequency blood-pressure variability was unaffected by peripheral epinephrine or esmolol, supporting distinct information from PEP and BPV about cardiac activation and central sympathetic control.
4
Norepinephrine-mediated central sympathetic inhibition decreased low-frequency systolic BP variability by 0.67 ± 0.13 ln mm Hg².
5
The study empirically distinguishes peripheral cardiac sympathetic activation from central sympathetic nervous system control using PEP and low-frequency systolic BP variability.
Research Object
Peripheral and central sympathetic nervous system activation in healthy men under pharmacologically induced cardiovascular and baroreflex changes
Research Subject
The separability and measurement patterns of peripheral cardiac sympathetic activation and central sympathetic control using preejection period and low-frequency blood pressure variability
Publication Details
Publication Date
2001-09-01
Journal
Publisher
ISSN
Access Type
Author Information
Download PDF
Subscribe to digest